Grifols GIFLF
NASDAQ GIFLF
$11.08 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Grifols (GIFLF) Change in Account Payables (2010 - 2022)

Grifols' (GIFLF) quarterly Change in Account Payables came in at $129.1 million in Q4 2022, up 602.21% quarter-over-quarter from -$25.7 million in Q1 2020.

Analysis

Grifols (GIFLF) Change in Account Payables (2010 - 2022) Analysis & Trends

Grifols (GIFLF) has reported Change in Account Payables for 12 consecutive years, with $129.1 million the latest figure, recorded in Q4 2022.

  • For the quarter ending Q4 2022, Change in Account Payables changed N/A year-over-year to $129.1 million; the trailing twelve-month figure through Dec 2022 stood at -$30.6 million (changed N/A YoY), and the FY2025 full-year result was $106.2 million, up 242.71% from the prior year.
  • Change in Account Payables advanced to $129.1 million in Q4 2022 per GIFLF's latest filing, from -$25.7 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $129.1 million in Q4 2022 and bottomed at -$78.2 million in Q4 2019.
  • Historically, Change in Account Payables has averaged -$5.9 million across 4 years, with a median of -$22.7 million in 2018.
  • The sharpest annual moves came in 2019 and 2020: Change in Account Payables sank 1957.3% in 2019, then soared 53.91% in 2020.
  • Over 4 years, Change in Account Payables stood at $4.2 million in 2018, then tumbled by 1957.3% to -$78.2 million in 2019, then soared by 67.14% to -$25.7 million in 2020, then jumped by 602.21% to $129.1 million in 2022.
  • According to Business Quant data, Change in Account Payables over the past three periods registered $129.1 million, -$25.7 million, and -$78.2 million for Q4 2022, Q1 2020, and Q4 2019 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn -70.00 Mn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn 18.00 Mn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn -66.70 Mn
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn -
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn -
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn -8.00 Mn
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn -
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn -
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn 7.11 Mn
10 Grifols 7.54 Bn 9.09 Bn 3.33 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 129.08 Mn
Mar 31, 2020 -25.70 Mn
Dec 31, 2019 -78.22 Mn
Mar 31, 2019 -55.77 Mn
Dec 31, 2018 4.21 Mn
Jun 30, 2018 -22.71 Mn
Mar 31, 2018 8.02 Mn
Dec 31, 2017 48.35 Mn
Jun 30, 2017 34.54 Mn
Mar 31, 2017 19.09 Mn
Dec 31, 2016 81.49 Mn
Sep 30, 2016 -70.38 Mn
Dec 31, 2015 -282.65 Mn
Sep 30, 2015 21.41 Mn
Jun 30, 2015 337.12 Mn
Mar 31, 2015 -182.68 Mn
Dec 31, 2014 94.13 Mn
Sep 30, 2014 122.80 Mn
Jun 30, 2014 -70.78 Mn
Mar 31, 2014 70.80 Mn